All News

During this illustrative podcast of six episodes Amsterdam institute for Infection and Immunity researchers and AIGHD fellows Marc van der Valk, Professor in Internal Medicine, and Peter Reiss, Professor in Medicine, guide you through the world of HIV together with the podcast hosts Loiza Lamers...

On Monday, 9 January, we will be celebrating the 391st anniversary of the University of Amsterdam. You are cordially invited to the celebration of the Dies Natalis in the Aula. AIGHD Senior Fellow, Charles Agyemang, professor of Migration and Health, has been given the honor of delivering...

Experts awarded highest scientific honor in Vietnam A group of infectious disease experts combating the spread of tuberculosis in Vietnam has been recognised for their extensive research and advocacy, which has spanned over the course of a decade. The dedication of a group of researchers safeguarding...

It is with great pride we announce that Arjen Dondorp has been appointed Full Professor. As of 01 November 2022, Arjen Dondorp has been appointed full Professor of Translational Global Health at the University of Amsterdam. His chair resides in the Department of Global Health,...

AIGHD welcomes the new Dutch Global Health Strategy 2023 – 2030. The first of its kind, it will be an essential foundation for concerted government and stakeholder actions to address important health challenges that threaten not only the Netherlands and Europe, but especially low- and...

The movement from one country to another, whether by choice or by force, is a reality that we continue to confront around the world. It is the specific health consequences, physically and mentally, resulting from this movement that sit at the intersection of migration and...

"Yes, yes, yes, yes,” in the experience of Dr. Charles Agyemang, AIGHD Senior Fellow and Professor of Global Migration, Ethnicity and Health, this refrain is an all-too-common experience for doctors seeing a recent migrant for the first time. It might seem efficient but this agreeableness...

The INDIGO project, coordinated by AIGHD, has begun its phase 1 trial of a novel low-dose influenza vaccine that combines 1/5th of a dose of a licensed influenza vaccine with a new adjuvant, an ingredient used in several vaccines to help create a stronger immune...